Pro B - Search Results

1

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.

Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. Carson KR, et al. Among authors: pro b. Cancer. 2017 Apr 1;123(7):1174-1183. doi: 10.1002/cncr.30416. Epub 2016 Dec 2. Cancer. 2017. PMID: 27911989 Free PMC article.

2

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.

Wilder RB, Rodriguez MA, Ha CS, Pro B, Hess MA, Cabanillas F, Cox JD. Wilder RB, et al. Among authors: pro b. Cancer. 2001 Jun 15;91(12):2440-6. Cancer. 2001. PMID: 11413536

3

International prognostic index-based outcomes for diffuse large B-cell lymphomas.

Wilder RB, Rodriguez MA, Medeiros LJ, Tucker SL, Ha CS, Romaguera JE, Pro B, Hess MA, Cabanillas F, Cox JD. Wilder RB, et al. Among authors: pro b. Cancer. 2002 Jun 15;94(12):3083-8. doi: 10.1002/cncr.10583. Cancer. 2002. PMID: 12115338 Free article.

4

Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.

Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, Younes A, McLaughlin P, Goy A, Sarris AH, Dang NH, Samaniego F, Brown HM, Gagneja HK, Cabanillas F. Romaguera JE, et al. Among authors: pro b. Cancer. 2003 Feb 1;97(3):586-91. doi: 10.1002/cncr.11096. Cancer. 2003. PMID: 12548600 Free article.

5

Thalidomide for patients with recurrent lymphoma.

Pro B, Younes A, Albitar M, Dang NH, Samaniego F, Romaguera J, McLaughlin P, Hagemeister FB, Rodriguez MA, Clemons M, Cabanillas F. Pro B, et al. Cancer. 2004 Mar 15;100(6):1186-9. doi: 10.1002/cncr.20070. Cancer. 2004. PMID: 15022285 Free article.

6

Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Dabaja BS, et al. Among authors: pro b. Cancer. 2004 Aug 1;101(3):518-26. doi: 10.1002/cncr.20404. Cancer. 2004. PMID: 15274064 Free article.

7

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma.

Oki Y, McLaughlin P, Pro B, Hagemeister FB, Bleyer A, Loyer E, Younes A. Oki Y, et al. Among authors: pro b. Cancer. 2005 Aug 15;104(4):781-7. doi: 10.1002/cncr.21219. Cancer. 2005. PMID: 15973667 Free article. Clinical Trial.

8

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.

Oki Y, McLaughlin P, Fayad LE, Pro B, Mansfield PF, Clayman GL, Medeiros LJ, Kwak LW, Srivastava PK, Younes A. Oki Y, et al. Among authors: pro b. Cancer. 2007 Jan 1;109(1):77-83. doi: 10.1002/cncr.22389. Cancer. 2007. PMID: 17133412 Free article.

9

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

Jabbour E, Hosing C, Ayers G, Nunez R, Anderlini P, Pro B, Khouri I, Younes A, Hagemeister F, Kwak L, Fayad L. Jabbour E, et al. Among authors: pro b. Cancer. 2007 Jun 15;109(12):2481-9. doi: 10.1002/cncr.22714. Cancer. 2007. PMID: 17497648 Free article.

10

Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics.

Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B. Husain A, et al. Among authors: pro b. Cancer. 2007 Aug 15;110(4):809-15. doi: 10.1002/cncr.22843. Cancer. 2007. PMID: 17594698 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page